Last reviewed · How we verify

NCT06814015

Self-balancing Personal Exoskeleton for SCI (Site 2)

Recruiting now NA Last updated 2 February 2026
What this trial tests

NA trial testing Hands-free exoskeleton in Spinal Cord Injuries (SCI) in 24 participants. Currently enrolling.

Timeline
31 March 2025
Primary endpoint
31 May 2026
31 May 2026

Quick facts

Lead sponsorWandercraft
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment24
Start date31 March 2025
Primary completion31 May 2026
Estimated completion31 May 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Wandercraft

Who can join

18 and older, any sex, with Spinal Cord Injuries (SCI) or Paraplegia and Tetraplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hands-free exoskeleton

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injuries (SCI)

Currently open trials in the same condition.

Other Wandercraft trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06814015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing